You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Mexico

May 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Mexico with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Mexico, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Mexico for free:

The Consumer Health in Mexico market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Mexico?
  • What are the major brands in Mexico?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Economic factors affect the performance of consumer health

The economic crisis in the country leadd most industries in 2009 with consumer health being no exception. Growth was very modest in retail sales, with volume sales showing a marginal decrease. This fact, teamed with the normal growth in population signalled a lower per capita consumption of health products in the country over the review period.

Generic products growth at record numbers

With consumers searching for competitive prices, generic products took the lead in 2009. Generic products were already present in large grocery retailers (mostly Wal-Mart with Equate brand and Comercial Mexicana with Farmacon) and pharmacy chains Farmacias de Similares, Farmacias del Ahorro). But generic products with the new line Primer Nivel by Genomma Lab Internacional SAB de CV and some domestic manufacturers which started to launch more generic products fuelled their outstanding growth and were distributed by large retailers, pharmacy chains, independent pharmacies, and even variety stores like Sanborns.

Domestic manufacturers take the lead on growth

It is a known fact that branded products are expected to underperform vis a vis generic not only for pricing reasons. There is one more reason for this state of affairs: the patent of a number of medicines (around 15 in 2011) will have their patent terms come to an end, which places greater opportunity for generics to enter these medicines. If we also consider that new product development from the large pharmaceutical companies are lagging in launching successful patent medicines, then an opportunity will arise for generics manufactured by domestic companies.

Large grocery and pharmacy chains continue to take share from independents

There were over 27,000 chemists/pharmacies and parapharmacies/drugstores in the country at the end of the review period, out of which 8,000 were chained businesses. While independent businesses continue to distribute the bulk of over-the-counter and nutritional products, the importance of chained grocery retailers is steadily growing since this channel continues to expand all across the country. As these chained grocery retailers engage in successful practices of pharmacies (such as opening small and inexpensive medical consultation offices) prospects will continue to be favourable.

Modest growth is expected over the forecast period

Large pharmaceutical companies launching minimal amounts of successful new drugs and products, consumers searching for competitive prices and turning to generic medicines a weak economic recovery, and more domestic laboratories developing generic products along with the easing of imports of OTC products freely from North America will nearly guarantee an increase in sales over the early part of the forecast period.

Table of Contents

Table of Contents

Consumer Health in Mexico - Industry Overview

EXECUTIVE SUMMARY

Economic factors affect the performance of consumer health

Generic products growth at record numbers

Domestic manufacturers take the lead on growth

Large grocery and pharmacy chains continue to take share from independents

Modest growth is expected over the forecast period

KEY TRENDS AND DEVELOPMENTS

OTC Medication from North America gets green light

Generic continue to soar in popularity

Climate change begins to influence the pharmaceutical industry

Demographic trends shape consumption of consumer health products

The new Seguro Popular programme can increase demand for OTC products

Enforcement for prescriptions to obtain antibiotics drive sales of multivitamins and cold remedies

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Mexico - Company Profiles

Bayer de México SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Bayer de México SA de CV: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 6 Bayer de México SA de CV: Competitive Position 2010

Boehringer Ingelheim Promeco SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 9 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 10 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2010

Farmacias Similares SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Farmacias Similares SA de CV: Competitive Position 2010

Genomma Lab Internacional SAB de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Genomma Lab Internacional SAB de CV: Competitive Position 2010

GlaxoSmithKline México SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 19 GlaxoSmithKline México SA de CV: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 20 GlaxoSmithKline México SA de CV: Competitive Position 2010

Herbalife Internacional de México SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 23 Herbalife Internacional de México SA de CV: Competitive Position 2010

Merck-México SA in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 26 Merck-México SA: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 27 Merck-México SA: Competitive Position 2010

Pfizer SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 30 Pfizer SA de CV: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 31 Pfizer SA de CV: Competitive Position 2010

Adult Mouth Care in Mexico - Category Analysis

TRENDS

  • In 2010, adult mouth care registered a discreet increase in retail sales of 2% to reach Mx$243 million.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Mexico - Category Analysis

HEADLINES

TRENDS

  • After a unfortunate 2009 in which economic activity registered a serious drop, demand for analgesics registered a bounce back of 2% retail value growth in 2010 compared to -1% the previous year. As analgesics is a mature category with a number of well known brands and products in great demand, neither the drop nor the gain were too severe, considering that the past economic crisis was the worst in seven decades. Analgesics retained popular products, and consumers continued to demand them in large quantities, but the trading down trend was an ongoing phenomenon, since generic products continued to increase their share. Actually, the performance of analgesics in 2010, recovering the loss of the previous year and a little extra, was expected, since as a mature category it is not expected to register drastic changes.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bristol-Myers Squibb de México SA de CV is the leading manufacturer of analgesics in the country, with a total retail value sales share of 19% in 2010. Bristol-Myers has a number of highly demanded products such as Tempra (sold as an acetaminophen and a combination product). Ranked second was Grupo Roche Syntex de Mexico held 13% share of retail value sales with successful bands such as Flanax (offered at regular and child-specific version Naproxen). It seems a profitable practice from leading companies to offer a number of presentations of their most successful brands to profit from them in more than one division.

PROSPECTS

  • Prospects for OTC products in general and for analgesics in particular will be highly influenced in years to come by demographics. Mexico, as well as many of the emerging countries is ageing; women passed from having a large offspring to having only two children per woman in a couple of decades. This fact, combined with an increasing life expectation which will create a larger group of people aged 60 years and over will increase the demand for more medications and health services. The category of analgesics is prone to have a high drive in sales due to this situation since treating inflammation and pain is one of the most common demands among the elderly. Mirroring this situation, child-specific analgesics, a segment that remained underdeveloped, is likely to continue as a small division for the foreseeable future since a low birth rate and one which is lowering every year seems to be the population trend for the coming years.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Mexico - Category Analysis

TRENDS

  • In 2010, calming and sleeping grew by 3%, reaching Mx$95 million, the second smallest OTC category in retail value sales after ear care. Despite that the fact that this category is very small, it is considerably fragmented with only one company holding more than 25% share of total retail value sales and only one holding more than 10% share of total sales.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2005-2010
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 26 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 27 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Mexico - Category Analysis

HEADLINES

TRENDS

  • After a bad 2009 that brought the worst economic crisis in decades, cough, cold and allergy (hay fever) remedies registered a sizeable decrease in sales since it went from a rate of 6% in 2008 to a rise of only 1% in 2009. The sanitary emergency of the AH1N1 virus helped this category to avoid a larger drop since many consumers acquired OTC remedies related to the respiratory system to fight the spread of the virus. During 2010, with no sanitary events helping this category but with a much improved economy, it was able to achieve a notable recovery by increasing retail sales by 2%.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cadbury Adams Mexico S De RL De CV is the leading sales company of cough, cold and allergy (hay fever) remedies holding 21% share of current retail value sales. The fact that a confectionery and snacks company can lead an OTC category stems from the fact that its Halls medicated confectionery is extremely successful in the country, selling Mx$1.6 billion in 2010; more than some complete segments within the industry, and dominating medicated confectionery with 94% retail value share. As previously mentioned Mexicans consume medicated confectionery like sweets, with most of them hardly regarding it as a medicinal product and even use it with no signs of any illness or discomfort. Schering-Plough SA de CV is a distant second with 9% share of total sales by selling hit products Desenfriol, Afrin and Clarityne.

PROSPECTS

  • Prospects for cough, cold and allergy (hay fever) remedies are good with a constant retail value CAGR of 2%. Now that the AH1N1 virus is under control and federal health authorities are closely monitoring the potential surge of another virus or bacteria causing a sanitary crisis there are few, if any, events that lead to think that this category will witness drastic variations in demand. This is a mature category where variations (seasonal, peak at winter time) are expected. Generics is also expected to continue performing well as more and more consumers realise that the active ingredients in generic and private label products are the same as those in branded products.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Mexico - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies experienced healthy demand for a number of years. Given that Mexican cuisine is typically spicy and greasy means that locals have a long history of digestive complaints that are usually solved with OTC digestive medication. This prevalent situation has produced some very successful brands such as Pepto-Bismol, Alka-Seltzer and Sal de Uvas Picot are now synonymous with digestive remedies and part of most domestic households. Digestive remedies is a category that continues to grow and even the difficult economic situation of 2009 could not prevent it from increasing (yet at a lower rate than in previous years), while during 2010 the category kept increasing in sales at reasonable rates (3%). 2010’s rate was even lower than 2009 (2%). Other factors such as an ageing population and elevated stress levels keep digestive products in healthy demand.

SWITCHES

COMPETITIVE LANDSCAPE

  • The competitive landscape of digestive remedies is very fragmented, with only one company making more than 10% of total sales. Pisa Laboratorios SA continued to lead sales by holding 11% share of total retail value sales due to the success of its Electrolit diarrhoeal remedy. The company has a number of brands in other divisions such as Agrulax within laxatives, but it is the huge popularity of Electrolit that amounted to Mx$458 million in 2010 and accounted for almost half the total sales of diarrhoeal remedies as well as 11% of all sales within the overall category of digestive remedies. Electrolit benefits from a presence in the country that dates decades back and by holding a large promotional campaign. As a close runner up, Abbot Laboratorios held 10% retail value share due to the success of its demanded Pedialyte brand, coincidentally another diarrhoeal remedy but this one targeting children. This situation reflects the high concentration of diarrhoeal products in several companies and the high demand for these products in the population.

PROSPECTS

  • Digestive remedies could be classified as a mature category that has been present in consumer health for decades due to the nature of Mexican cuisine, which is spicy and fatty. However, the category is constantly growing since the population is also constantly growing and all nationals are used to Mexican food despite its inconvenient after effects. Even people who follow a strict diet cannot avoid tasting the typical spicy Mexican food every now and again. This fact teamed with other factors such as higher stress levels, poor eating habits (too much processed food with low fibre) and even climate changes to ensure that in the foreseeable future digestive remedies will show a healthy, if not outstanding performance. This performance seems guaranteed even in the face of more financial constraints ahead, given that it grew during the very difficult 2009 period.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 42 Digestive Remedies Company Shares by Value 2006-2010
  • Table 43 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Mexico - Category Analysis

TRENDS

  • Ear care is, by far, the smallest OTC category and in 2010 it continued to decline in retail value sales, this time by -2% to account for only Mx$15.4 million.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2005-2010
  • Table 47 Sales of Ear Care: % Value Growth 2005-2010
  • Table 48 Ear Care Company Shares by Value 2006-2010
  • Table 49 Ear Care Brand Shares by Value 2007-2010
  • Table 50 Forecast Sales of Ear Care: Value 2010-2015
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Mexico - Category Analysis

TRENDS

  • In 2010, eye care registered a rather modest increase of 1% to reach Mx$375 million. There is a low demand for eye care products despite troubles created by pollution and large sized urban areas, and the growth is low, driven mostly by growth in the country´s population.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2005-2010
  • Table 53 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 54 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 55 Eye Care Company Shares by Value 2006-2010
  • Table 56 Eye Care Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 58 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Mexico - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional remedies in Mexico have a very long tradition that dates back for over 1,000 years. A large proportion of herbal remedies consumed in Mexico are produced in an artisanal way, and distributed via popular markets or tinguis and are very difficult to track. Given the wide acceptance of these products and their low pricing, it is easy for consumers to continue to purchase them even in times of economic hardship which explains the fact that during 2009 after the worst economic crisis of the past seven decades, the category witnessed only stagnant rather than declining value sales. However, a drastic rebound in sales (as witnessed in other consumer health categories) did not occur, since this mature category is now more likely to growth at levels similar to population growth rates.

COMPETITIVE LANDSCAPE

  • Cadbury Adams Mexico S De RL De CV accounted for 30% share of total retail value sales in 2010, given the large acceptance and penetration of medicated confectionery and the presence of its Halls products in Mexico for decades. Medicated confectionery is so widespread in the country that many people consumer it like sweets, without having any health issues. Herbalife Internacional de México SA de CV was ranked second with 12% of total sales in 2010 due to its Aloe brands. Following on the same medicated confectionery trend, Procter & Gamble de México comes as the running up company with 4% of total sales due to the sales of its Vick brand

PROSPECTS

  • Herbal/traditional products is a very mature category that dates back for centuries. This situation creates an industry that offers little opportunities for drastic changes, either growth or decline. It is expected that in the forecast period, herbal/traditional products will grow at discreet rates averaging 0.5% with little variation, increases that can be attributed mostly to the growth of the population.

CATEGORY DATA

  • Table 59 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 60 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 61 Herbal/Traditional Products Company Shares 2006-2010
  • Table 62 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 63 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 64 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Mexico - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care is a rather mature category in the country that is not used to registering large increases (always one digit figure for the past decade and usually less than 5%) nor notable decreases, even in the face of severe economic conditions. The category grew at a reasonable rate in 2010, registering a marginally lower increase when compared to a difficult 2009. Medicated skin care is placed on the right track for a steady increase in the coming years due to some factors such as the ongoing diabetes epidemic in the country (which some symptoms feature the apparition of fungal), poor dietary habits (haemorrhoid treatments) and an ageing population (hair loss treatments). In short, the category has experienced an ongoing upwards trend for the past few years and the review period and this situation is likely to extend further.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ranked first is Genomma Lab with 14% retail value share, followed by Laboratorios Dermatologicos Darier SA de CV de 9% and Schering-Plough SA de CV de Mexico with 7%. Bayer de Mexico with 6% thanks to leading topical and vaginal antifungal Canesten, which continuously run mass advertising campaign targeting women. Schering Plough competes with Lotrimin brand supported by strong advertising massive campaigns.

PROSPECTS

  • Medicated skin care is a somewhat mature category in the country, and yet there are three factors that lead to a promising future. One is demographics due to an ageing population that will demand more OTC skin products in the future for ailments more common in the elderly. Second is the prevalence of diabetes in the country and its recurrent high levels despite continuous governmental efforts to lower them down. Third is climate change that has made floods much more frequent (they are not a rare event but an expected yearly emergency), which tend to increase fungal infections.

CATEGORY DATA

  • Table 65 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 66 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 67 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 68 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 69 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 70 Acne Treatments Brand Shares by Value 2007-2010
  • Table 71 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Mexico - Category Analysis

HEADLINES

TRENDS

  • In Mexico, for the past decade the tobacco industry has been under a number of drastic reforms that have placed a series of strict regulations aiming to lower the number of smokers in the country. As of 2010, tobacco products faced a series of regulations that make it difficult for tobacco products to reach consumers: since 2008 a ban on smoking in public places took place, tobacco products can not advertise by any media at all with the sole exception of printed media (magazines) with content for adults (such as politics, economy, adult content); tobacco products are located out of the reach of the public and must be provided by sales personnel; tobacco products bear high taxation which will be increased again starting 2011; tobacco products must show graphic images regarding the medical dangers of tobacco consumption to mention just a few. However, all these measures have resulted in a moderate and not drastic smoking activity decrease from the approximately 14 million smokers in the country. In fact, during the severe economic crisis of 2009 it was observed that most smokers lowered on their regular consumption, and smoked fewer cigarettes per day instead of quitting the habit. This fact teams with the relative high cost of NRT cessation aid products to understand why these products showed even a small decrease in sales during the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Only two companies, both of them international players, divide the retail sales pie of NRT smoking cessation aids in Mexico. GlaxoSmithKline México SA de CV leads in retail sales by holding 44.5% of total retail sales due to its dominance with Niquitin products. Pharmacia & Upjohn SA de CV was second with 37% of total sales in 2010 with Nicorette within NRT gum segment. GlaxoSmithKline is the runner up by holding up to 44.5% of total retail sales due to its dominance in patches: close to 78% of total sales in patches belong to the Niquitin brand by GlaxoSmithKline.

PROSPECTS

  • It is doubtful that even if the tobacco industry retains its strict regulations that discourage tobacco consumption, the demand for NRT smoking cessation aids will increase significantly. In fact, for at least the term of the review period, the tobacco industry has been under strict rules and that has had a very limited impact on the demand for NRT smoking cessation aids. The reason is that these products tend to be expensive and locals tend to use their will power when attempting to stop smoking.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 78 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 79 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Mexico - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition in Mexico experienced a strong attack from counterfeit products from the US over the review period. According to industry sources, while pirate products are very few, counterfeits accounted for over 50% of all products consumed in Mexico. This flooding of counterfeits forced domestic established businesses to keep prices down. This situation clearly worsens a category in which economic factors have a large influence on sales results which were notably damaging in 2009 with a 3% decline and did not help much a year later, since 2010 was almost stagnant with marginal growth. All this in a category that has slowly expanded on its target consumer base from affluent consumers a few years ago to middle- income earners at the end of the review period.

COMPETITIVE LANDSCAPE

  • The competitive landscape of sports nutrition in Mexico is leadd by two domestic companies, Pronat with 19% share of total retail value sales and Nutrisa with 14%. These two companies help domestic manufacturers to account for approximately 44% share of total retail sales, leaving 56% retail sales to international manufacturers (best known are Abbott Laboratorios, MuscleTech Research & Development and Universal Nutrition Inc). Two domestic companies hold the largest sales share at around one third of total retail sales despite the reputation of international manufacturers (most of them from the US). As mentioned earlier, a large proportion of Mexican consumers perceive sport nutrition as unnatural and risky, but Pronat and Nutrisa have built a reputation for years for manufacturing natural and healthy products: Pronat has an extensive line of health, natural-based supplements same as Nutrisa, which allow them to promote their sports nutrition brands as natural-based and more healthy than imported products. Furthermore, both companies benefit from an outstanding distribution system unmatched by any competitor. While Nutrisa has its own healthfood shops (over 300 around the country), Pronat reaches many of the small healthfood shops nationwide and its products are even sold in Nutrisa shops. Pronat’s ProWinner is also one of the few brands to be present at the Wal-Mart stores.

PROSPECTS

  • Sports nutrition has chance for growth as long as the population continues to increase and as long as the obesity rates and diabetes epidemic of the review period encourages consumers to practice more physical activities. Sports nutrition is highly likely to rebound over the forecast period, achieving modest but steady growth for a number of reasons: the increasing recognition of sports products by a niche of the population, the increasing counterfeits from the north and south borders, stability of currency and increasing sporting rates in the population due to obesity concerns.

CATEGORY DATA

  • Table 82 Sales of Sports Nutrition: Value 2005-2010
  • Table 83 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 84 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 85 Sports Nutrition Company Shares 2006-2010
  • Table 86 Sports Nutrition Brand Shares 2007-2010
  • Table 87 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 88 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Mexico - Category Analysis

HEADLINES

TRENDS

  • After a terrible performance in 2009 in which vitamins and dietary supplements remained near flat despite the strong performance of vitamin C due to the AH1N1 health scare, the category experienced a notable boost in sales in 2010, increasing retail value sales by 10%, led by the always important multivitamins segment which increased in sales by 10%. Health authorities are not known to make health campaigns promoting a specific health product but to make campaigns supporting the general well being of the population. In the winter season, some government authorities on a state and municipal level encourage the population to consume vitamin C products but do not promote a specific brand.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Vitamins and dietary supplements is a highly fragmented category in Mexico, with dozens of small companies operating with an artisanal production line and with only one company, Herbalife, holding over 27% share of total retail value. The company benefits from targeting a wide population base, the low and middle-income consumers and by having a large number of individual distributors. Herbalife benefits also from holding and maintaining the image of a company that manufactures natural based products. Herbalife registered gained the most retail value share in 2010 with 3.5 percentage points. Ranked second was Farmacias Similares with 7% retail value share benefiting from targeting mostly low-income consumers and by having their own network of 4,000 drugstores that sell their own products. No other retailer in the country has such a large distribution network, and Farmacias Similares praises itself in helping low-income consumers in obtaining not only vitamins and dietary supplements but prescription and OTC drugs to the vast low-income population in the country.

PROSPECTS

  • For the forecast period, vitamins and dietary supplements is expected to increase in constant retail value sales by an overall 21%, reaching Mx$11 billion in 2015. The sale of vitamins and dietary supplements in Mexico is strongly related to the overall performance of the economy. Since the vast majority of the population still regards vitamins and dietary supplements as a luxury or nice to have for one’s health, a rise in discretionary income is of paramount importance to the good sales performance of this category. However, there is a demographic trend that allows players to be optimistic and that is the ongoing ageing of the population. In fact, the segment of people aged 60 years or older will grow by over 20% over the forecast period, passing from 8.5% of the total population to 10%. This large increase in just five years will mean consumers demanding more vitamins and dietary supplements to maintain their health, most notably calcium supplements and multivitamins.

CATEGORY DATA

  • Table 89 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 90 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 91 Dietary Supplements by Positioning 2005-2010
  • Table 92 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 93 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 94 Vitamins Brand Shares by Value 2007-2010
  • Table 95 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 97 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 32 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in Mexico - Category Analysis

HEADLINES

TRENDS

  • The high demand for weight control products in the country, fuelled by the increasing obesity trends, was also brought to the attention of the federal health authorities. The Ministry of Health via the COFEPRIS continued to monitor and regulate several ingredients of the emerging weight management products. The use of Thevetia and chromium picolinate (linked to cardiovascular, neurological and dermatological damage) was banned in 2009, by October 2010; the COFEPRIS removed all weight management products containing sibutramine for harming the cardiovascular system. Some commercial brands affected were Adecid, Adelseril, Affilare, Amuprux ASF, Basistram, Broclas, Ectiva, Gea, Kifenip, N-ti, Reductil, Randism, Serotramin, Siruton, Tramicell, Yeduc, IFA Certez Duo, Slimtral M and Redumed.

COMPETITIVE LANDSCAPE

  • The competitive environment in the country for weight management is highly concentrated, with few companies dominating the whole category. The leading sales company, Herbalife, makes alone 34% retail value share. Herbalife claims an outstanding distribution network of over 400,000 independent distributors, and such a vast network cannot be matched by any other company. Ranked second was Slim-Fast Foods Co which accounted for 8% retail value share with its very successful and highly recognisable Slim Fast brand (with decades present in Mexico). Slim Fast is the second most successful brand, just behind Herbalife.

PROSPECTS

  • Given the extremely severe rates of obesity and people being overweight that Mexico suffers from and the diabetes epidemic, it is easy to forecast continuous growing retail sales for weight management products. However, this growth will be followed by an equally increasing attention from health authorities which will continue to ban products and ingredients that prove risky for the health of consumers. The COFEPRIS and the Ministry of Health will not only keep an eye on weight management products in Mexico, they will likely issue some legislation to actually prevent these products from reaching consumers. At the end of the review period, the legislation for dietary supplements was fairly permissive and this situation was taken as an advantage from non-reliable manufacturers that entered the category with weight control products but register them as dietary supplements. A more restrictive legislation is said to be in progress to prevent this situation but it is difficult to know if and when this will pass. In addition, legal restrictions over weight management products that make deceptive advertising is complementary on a more restrictive legislation package that will regulate this market.

CATEGORY DATA

  • Table 98 Sales of Weight Management: Value 2005-2010
  • Table 99 Sales of Weight Management: % Value Growth 2005-2010
  • Table 100 Weight Management Company Shares 2006-2010
  • Table 101 Weight Management Brand Shares 2007-2010
  • Table 102 Forecast Sales of Weight Management: Value 2010-2015
  • Table 103 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Mexico - Category Analysis

TRENDS

  • In 2010, wound care grew by 1% in current retail value terms, accounting for Mx$240 million. This is a mature category with considerably stable and low growth rates but in the coming years some higher growth can be expected due to the diabetes epidemic and the elderly suffering from muscular pain.

CATEGORY DATA

  • Table 104 Sales of Wound Care by Category: Value 2005-2010
  • Table 105 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 106 Wound Care Company Shares by Value 2006-2010
  • Table 107 Wound Care Brand Shares by Value 2007-2010
  • Table 108 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 109 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Isoflavones
            • Nopal
            • Spirulina
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking incidence

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report